162 related articles for article (PubMed ID: 11102418)
1. Linezolid against penicillin-sensitive and -resistant pneumococci in the rabbit meningitis model.
Cottagnoud P; Gerber CM; Acosta F; Cottagnoud M; Neftel K; Täuber MG
J Antimicrob Chemother; 2000 Dec; 46(6):981-5. PubMed ID: 11102418
[TBL] [Abstract][Full Text] [Related]
2. Combined treatment with ceftriaxone and linezolid of pneumococcal meningitis: a case series including penicillin-resistant strains.
Faella F; Pagliano P; Fusco U; Attanasio V; Conte M
Clin Microbiol Infect; 2006 Apr; 12(4):391-4. PubMed ID: 16524418
[TBL] [Abstract][Full Text] [Related]
3. Bacteriostatic or bactericidal effect of linezolid against multiresistant Streptococcus pneumoniae.
Malm A; Korona-Głowniak I; Biernasiuk A; Kalasiewicz A; Juda M
New Microbiol; 2008 Jul; 31(3):363-70. PubMed ID: 18843891
[TBL] [Abstract][Full Text] [Related]
4. Daptomycin is highly efficacious against penicillin-resistant and penicillin- and quinolone-resistant pneumococci in experimental meningitis.
Cottagnoud P; Pfister M; Acosta F; Cottagnoud M; Flatz L; Kühn F; Müller HP; Stucki A
Antimicrob Agents Chemother; 2004 Oct; 48(10):3928-33. PubMed ID: 15388454
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of telavancin against penicillin-resistant pneumococci and Staphylococcus aureus in a rabbit meningitis model and determination of kinetic parameters.
Stucki A; Gerber P; Acosta F; Cottagnoud M; Cottagnoud P
Antimicrob Agents Chemother; 2006 Feb; 50(2):770-3. PubMed ID: 16436742
[TBL] [Abstract][Full Text] [Related]
6. Grepafloxacin against penicillin-resistant pneumococci in the rabbit meningitis model.
Gerber CM; Tovar L; Cottagnoud M; Neftel KA; Täuber MG; Cottagnoud P
J Antimicrob Chemother; 2000 Aug; 46(2):249-53. PubMed ID: 10933648
[TBL] [Abstract][Full Text] [Related]
7. Activities of ertapenem, a new long-acting carbapenem, against penicillin-sensitive or -resistant pneumococci in experimental meningitis.
Cottagnoud P; Pfister M; Cottagnoud M; Acosta F; Täuber MG
Antimicrob Agents Chemother; 2003 Jun; 47(6):1943-7. PubMed ID: 12760871
[TBL] [Abstract][Full Text] [Related]
8. In vivo pharmacodynamics of a new oxazolidinone (linezolid).
Andes D; van Ogtrop ML; Peng J; Craig WA
Antimicrob Agents Chemother; 2002 Nov; 46(11):3484-9. PubMed ID: 12384354
[TBL] [Abstract][Full Text] [Related]
9. In vitro activities of oxazolidinones U-100592 and U-100766 against penicillin-resistant and cephalosporin-resistant strains of Streptococcus pneumoniae.
Mason EO; Lamberth LB; Kaplan SL
Antimicrob Agents Chemother; 1996 Apr; 40(4):1039-40. PubMed ID: 8849225
[TBL] [Abstract][Full Text] [Related]
10. Antipneumococcal activity of AZD2563, a new oxazolidinone, compared with nine other agents.
Peric M; Lin G; Clark CL; Jacobs MR; Appelbaum PC
J Antimicrob Chemother; 2002 Jul; 50(1):95-100. PubMed ID: 12096012
[TBL] [Abstract][Full Text] [Related]
11. Ceftriaxone acts synergistically with levofloxacin in experimental meningitis and reduces levofloxacin-induced resistance in penicillin-resistant pneumococci.
Flatz L; Cottagnoud M; Kühn F; Entenza J; Stucki A; Cottagnoud P
J Antimicrob Chemother; 2004 Feb; 53(2):305-10. PubMed ID: 14729741
[TBL] [Abstract][Full Text] [Related]
12. Cefepime is efficacious against penicillin- and quinolone-resistant pneumococci in experimental meningitis.
Cottagnoud P; Acosta F; Cottagnoud M; Täuber MG
J Antimicrob Chemother; 2002 Feb; 49(2):327-30. PubMed ID: 11815575
[TBL] [Abstract][Full Text] [Related]
13. Efficacies of BMS 284756 against penicillin-sensitive, penicillin-resistant, and quinolone-resistant pneumococci in experimental meningitis.
Cottagnoud P; Acosta F; Cottagnoud M; Pfister M; Täuber MG
Antimicrob Agents Chemother; 2002 Jan; 46(1):184-7. PubMed ID: 11751131
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of cefepime alone and in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro.
Gerber CM; Cottagnoud M; Neftel K; Täuber MG; Cottagnoud P
J Antimicrob Chemother; 2000 Jan; 45(1):63-8. PubMed ID: 10629014
[TBL] [Abstract][Full Text] [Related]
15. Linezolid and vancomycin, alone and in combination with rifampin, compared with moxifloxacin against a multidrug-resistant and a vancomycin-tolerant Streptococcus pneumoniae strain in an in vitro pharmacodynamic model.
Cha R; Rybak MJ
Antimicrob Agents Chemother; 2003 Jun; 47(6):1984-7. PubMed ID: 12760880
[TBL] [Abstract][Full Text] [Related]
16. Comparative activities of the oxazolidinone AZD2563 and linezolid against selected recent North American isolates of Streptococcus pneumoniae.
Baum SE; Crawford SA; McElmeel ML; Whitney CG; Jorgensen JH
Antimicrob Agents Chemother; 2002 Sep; 46(9):3094-5. PubMed ID: 12183281
[TBL] [Abstract][Full Text] [Related]
17. Trovafloxacin in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model.
Rodoni D; Hänni F; Gerber CM; Cottagnoud M; Neftel K; Täuber MG; Cottagnoud P
Antimicrob Agents Chemother; 1999 Apr; 43(4):963-5. PubMed ID: 10103211
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of moxifloxacin, a new 8-methoxyquinolone, for treatment of meningitis caused by a penicillin-resistant pneumococcus in rabbits.
Ostergaard C; Sørensen TK; Knudsen JD; Frimodt-Møller N
Antimicrob Agents Chemother; 1998 Jul; 42(7):1706-12. PubMed ID: 9661008
[TBL] [Abstract][Full Text] [Related]
19. Linezolid, levofloxacin, and vancomycin against vancomycin-tolerant and fluoroquinolone-resistant Streptococcus pneumoniae in an in vitro pharmacodynamic model.
Cha R; Akins RL; Rybak MJ
Pharmacotherapy; 2003 Dec; 23(12):1531-7. PubMed ID: 14695032
[TBL] [Abstract][Full Text] [Related]
20. In vitro selection of mutants of Streptococcus pneumoniae resistant to macrolides and linezolid: relationship with susceptibility to penicillin G or macrolides.
Carsenti-Dellamonica H; Galimand M; Vandenbos F; Pradier C; Roger PM; Dunais B; Sabah M; Mancini G; Dellamonica P
J Antimicrob Chemother; 2005 Oct; 56(4):633-42. PubMed ID: 16135525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
